NUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10MG

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,07 report with the FDA on 2010-02-17 for NUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10MG manufactured by Genentech, Inc..

Event Text Entries

[1319564] Pen malfunctioned when she inserted a refill cartridge [overdose]. Case description: this case, (b)(4), is an spontaneous report from the united states referring to a (b)(6), female, patient. A consumer, who is a retired nurse, reported this case. Past medical history included "pre-diabetic", blood follicle stimulating hormone decreased, fibromyalgia, gout, and tobacco user. Negative medical history included drug hypersensitivity. The patient had no known drug allergies. No allergies or concurrent illnesses were reported. Concomitant medications included diazepam, methadone hydrochloride, allopurinol, hydrochlorothiazide, lisinopril, levothyroxine sodium, acetaminophen, and hydrocodone bitartrate. In (b)(6) 2009, the patient received somatropin (0. 2 mg, qd, subcutaneous, lot number 784456) via nutropin aq pen (lot number u088) for the indication of adult growth hormone deficiency. The most recent date of administration prior to the event was (b)(6) 2010. The patient reported that when she began using nutropin aq pen she took it to her physician's office, and she and the nurse in the office determined how to use it from the patient instructions provided in the nutropin aq pen carton. The office nurse and the patient had not seen a nutropin aq pen prior to that time. The patient did not receive training on the use of the nutropin aq pen via the "training dvd". On (b)(6) 2010, the patient experienced nutropin aq pen malfunction when she inserted a refill cartridge, and experienced subsequent overdose (overdose). Initially the refill cartridge held 10 mg. The patient primed the cartridge losing an unspecified amount of medication. After priming, the patient injected her first dose with this cartridge. After priming and injection, approximately 5 to 7 mg of medication remained in the cartridge. The patient reported that nutropin aq pen did not stop as usual after she started the injection, but kept going. The patient reported that she did not experience any symptoms following the injection. No relevant laboratory tests were reported. The puncture date of the vial in question was not specified. The type of storage of the product was not reported. It was not reported whether the patient retained the complaint vial/device, or whether it was discarded. Action taken with somatropin and/or nutropin aq pen was not reported. On (b)(6) 2010, in-home training for nutropin aq pen injection technique was offered to the patient. The patient declined this offer. The event outcome was not reported. The consumer did not report a specific causality assessment of the event overdose as related to somatropin and/or nutropin aq pen. The consumer noted that the nutropin aq pen may be defective. No other suspect cause was reported. No further information is expected. (b)(4).
Patient Sequence No: 1, Text Type: D, B5


[8517370] Add'l lot # 784456.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2917293-2010-00001
MDR Report Key1620221
Report Source04,07
Date Received2010-02-17
Date of Report2010-01-15
Date Mfgr Received2010-01-15
Date Added to Maude2011-04-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactJAMES NICKAS, PHARM.D.
Manufacturer Street1 DNA WAY
Manufacturer CitySOUTH SAN FRANCISCO CA 94080
Manufacturer CountryUS
Manufacturer Postal94080
Manufacturer Phone6502255591
Manufacturer G1GENENTECH, INC.
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10MG
Generic NameNONE
Product CodeKZE
Date Received2010-02-17
Lot NumberU088
Device Expiration Date2011-06-01
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerGENENTECH, INC.


Patients

Patient NumberTreatmentOutcomeDate
10 2010-02-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.